按疫苗类型、适应症、给药途径和地区分類的鱼疫苗市场

2025 年全球鱼疫苗市场规模估计为 4.1 亿美元，预计到 2032 年将达到 7.646 亿美元，2025 年至 2032 年的复合年增长率为 9.3%。

数字。 2025 年鱼类疫苗市场占有率（按地区）

由于水产养殖业的兴起和致命鱼类疾病的日益流行，全球鱼类疫苗市场在过去几年中一直保持稳定成长。鱼类疫苗有助于保护鱼类族群免受感染疾病，并避免对养鱼者和贸易业者带来重大经济损失。该疫苗有助于为水产养殖中饲养的用于食用和观赏目的的鱼类接种疫苗。鱼贝类消费量的增加，以及对永续养鱼需求的不断增长，可能会在不久的将来导致全球对鱼类疫苗的需求增加。

市场动态

由于全球鱼贝类的需求不断增加，水产养殖实践的采用不断增加，可能会推动鱼类疫苗市场的成长。各种病毒和细菌感染（如弧菌病和上皮囊虫病）在养殖鲑鱼中日益流行，尤其是在欧洲和北美，这可能会促进鱼类疫苗的销售。然而，鱼疫苗研发的高成本以及新型鱼疫苗上市的严格规定可能会阻碍市场的成长。同时，采用新型佐剂技术开发高效的耐热鱼疫苗可能为工业製造商提供有利可图的机会。

研究的主要特点

• 本报告对全球鱼疫苗市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它揭示了不同领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球鱼疫苗市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球鱼疫苗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员可以透过分析全球鱼类疫苗市场所使用的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球鱼类疫苗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020-2032 年全球鱼类疫苗市场（按疫苗类型划分）（百万美元）

• 介绍
• 灭活疫苗
• 灭活疫苗
• 减毒疫苗
• 类毒素疫苗
• 次单位疫苗
• 结合疫苗
• 重组载体疫苗

6. 全球鱼类疫苗市场，依适应症，2020-2032 年（百万美元）

• 介绍
• 疖病
• 弧菌病
• 鼠疫桿菌
• 肠脓毒症
• 其他的

7. 2020-2032 年全球鱼类疫苗市场（依给药途径划分）（百万美元）

• 介绍
• 注射
• 浸没
• 喷
• 口服

8. 2020-2032 年全球鱼类疫苗市场（按地区划分）（百万美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • Merck Animal Health（MSD Animal Health）
  • Zoetis
  • Elanco
  • Virbac
  • HIPRA
  • Veterquimica SA
  • Tecnovax
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Nisseiken Co., Ltd.
  • Aquatic Animal Health Ltd
  • Ictyogroup
  • Benchmark Holdings plc
  • Vaxxinova
  • Alpha BIoTech Ltd.
  • Vallee SA
  • Ringpu Biology
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Chengdu Tech-bank Biological Products
  • Weiyuan Gene Tech

第 10 章分析师建议

• 兴衰
• 一致的机会地图

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Fish Vaccine Market is estimated to be valued at USD 410.0 Mn in 2025 and is expected to reach USD 764.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Figure. Fish Vaccine Market Share (%), By Region 2025

Global fish vaccine market has witnessed steady growth in the past few years, owing to rise in aquaculture industry and increasing prevalence of deadly fish diseases. Fish vaccines help prevent fish populations from infectious diseases, thus, avoiding heavy economic losses to fish farmers and traders. Vaccines aid immunization of fish species that are raised through aquaculture practices for both food and ornamental purposes. Growing consumption of seafood along with rising demand for sustainable fish farming can boost demand for fish vaccines globally in the near future.

Market Dynamics:

Increasing adoption of aquaculture practices due to rising global seafood demand can drive the fish vaccine market growth. Increasing prevalence of various viral and bacterial infections such as Vibriosis and Epitheliocystis disease particularly among salmon species farmed in Europe and North America can boost sales of fish vaccines. However, high costs associated with fish vaccine R&D and stringent regulations pertaining to launch of new fish vaccines can hamper the market growth. Meanwhile, introduction of novel adjuvant technologies for developing efficient thermostable fish vaccines can provide lucrative business opportunities for manufacturers in the industry.

Key Features of the Study:

• This report provides in-depth analysis of the global fish vaccine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global fish vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac, Hipra, Veterquimica S.A., Tecnovax, Anthropic, HIPRA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global fish vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish vaccine market

Detailed Segmentation-

• By Vaccine Type:
  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines
• By Indication:
  • Furunculosis
  • Vibriosis
  • Yersiniosis
  • Enteric septicaemia
  • Others
• By Route of Administration:
  • Injection
  • Immersion
  • Spray
  • Oral
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck Animal Health (MSD Animal Health)
  • Zoetis
  • Elanco
  • Virbac
  • HIPRA
  • Veterquimica S.A.
  • Tecnovax
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Nisseiken Co., Ltd.
  • Aquatic Animal Health Ltd
  • Ictyogroup
  • Benchmark Holdings plc
  • Vaxxinova
  • Alpha Biotech Ltd.
  • Vallee S.A.
  • Ringpu Biology
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Chengdu Tech-bank Biological Products
  • Weiyuan Gene Tech

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Indication
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Fish Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Fish Vaccine Market, By Vaccine Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Killed Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Inactivated Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Attenuated Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Toxoid Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Subunit Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Conjugate Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Recombinant Vector Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Fish Vaccine Market, By Indication, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Furunculosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Vibriosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Yersiniosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Enteric septicaemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fish Vaccine Market, By Route of Administration, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Immersion
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Spray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fish Vaccine Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck Animal Health (MSD Animal Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Virbac
  • HIPRA
  • Veterquimica S.A.
  • Tecnovax
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Nisseiken Co., Ltd.
  • Aquatic Animal Health Ltd
  • Ictyogroup
  • Benchmark Holdings plc
  • Vaxxinova
  • Alpha Biotech Ltd.
  • Vallee S.A.
  • Ringpu Biology
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Chengdu Tech-bank Biological Products
  • Weiyuan Gene Tech

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact